Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors
Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major…
Home rehab program improves lung function in bronchiectasis
A simple at-home program with daily exercise, airway clearance, and nurse support helps patients breathe easier, offering new…